713 results on '"Rodriguez, Paulo"'
Search Results
102. Data from Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via l-Arginine Metabolism
103. Data from Trp53 Inactivation in the Tumor Microenvironment Promotes Tumor Progression by Expanding the Immunosuppressive Lymphoid-like Stromal Network
104. Data from Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
105. Supplementary Figure 1 from Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via l-Arginine Metabolism
106. Supplementary Figures 1-6 from Trp53 Inactivation in the Tumor Microenvironment Promotes Tumor Progression by Expanding the Immunosuppressive Lymphoid-like Stromal Network
107. Supplementary Information from Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion
108. Supplementary Figure Legends 1-2 from Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
109. Supplementary Figure Legends 1-2 from Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via l-Arginine Metabolism
110. Supplementary Figure 2 from Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via l-Arginine Metabolism
111. Supplementary Figures 1-4, Table 1 from Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
112. Supplementary Figure 1 from Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
113. DRPPM-PATH-SURVEIOR: Plug-and-Play Survival Analysis of Pathway-level Signatures and Immune Components
114. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice
115. Arginine Metabolism, a Major Pathway for the Suppressive Function of Myeloid-Derived Suppressor Cells
116. Polyphenol-rich extract induces apoptosis with immunogenic markers in melanoma cells through the ER stress-associated kinase PERK
117. Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
118. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
119. Neglected no more: B cell-mediated anti-tumor immunity
120. DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4+ T-cell function without causing severe combined immunodeficiency
121. 1420 Targeting endoplasmic reticulum stress-responsive PERK in melanoma elicits paraptosis-mediated immunogenic cell death and induction of type I interferon-dependent adaptive antitumor immunity
122. 1147 Differences in co-expression of T cell co-inhibitory and co-stimulatory molecules with PD1 across different human cancers
123. 944 Targeting of notch ligand Jagged2 in lung cancer cells drives anti-tumor immunity via notch-induced functional reprogramming of tumor-associated macrophages
124. Additional file 9 of PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
125. Additional file 1 of PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
126. Additional file 2 of PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
127. Additional file 4 of PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
128. Additional file 6 of PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
129. Additional file 5 of PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
130. Additional file 7 of PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
131. Additional file 3 of PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
132. IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment
133. Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy
134. Myeloid-Derived Suppressor Cells in Cancer: Mechanisms and Therapeutic Perspectives
135. Myeloid-Derived Suppressor Cells in Cancer: Mechanisms and Therapeutic Perspectives
136. Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses
137. Affinity-matured DLL4 ligands as broad-spectrum modulators of Notch signaling
138. TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate
139. Arginase I levels are decreased in the plasma of pediatric patients with atopic dermatitis
140. Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas
141. Expression of Arginase I in Myeloid Cells Limits Control of Residual Disease after Radiation Therapy of Tumors in Mice
142. Arginine Availability Regulates T-Cell Function in Cancer
143. Arginase 1 promotes retinal neurovascular protection from ischemia through suppression of macrophage inflammatory responses
144. Mechanisms of Tumor Evasion
145. Tumor-directed dysregulation of erythroid progenitors drives immunosuppressive myeloid cells
146. Spontaneous class-switched antibody responses at endometrial cancer tumor bed drives superior patients’ outcome
147. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells
148. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T-cells
149. Immune Defects in T Cells From Cancer Patients : Parallels in Infectious Diseases
150. The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.